A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

In the current study, published today in the journal Nature Biotechnology, Cheng and his colleagues created an exosome system ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...

Cancer immunotherapy involves harnessing the body's immune system to fight tumors; however, delivering treatments effectively and precisely remains a ...